The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights.
Source link
Tags: C&E Executive News Filter, C&E Industry News Filter, Cancer Drugs, Content Types, corporate, corporate crime, Corporate Crime/Legal Action, Corporate/Industrial News, Crime, Crime/Legal Action, Domestic Politics, Factiva Filters, Financial Services, general news, government policy, Government Sponsored Health Insurance, Health, Health/Medical Insurance, healthcare, Healthcare/Life Sciences, industrial news, Insurance, international relations, legal action, life sciences, medical insurance, medications, Merck, MRK, Non-life Insurance, Pharmaceuticals, political, Political/General News, politics, Politics/International Relations, regulation, Regulation/Government Policy, specialized drugs, Specialized Drugs/Medications, SYND, WSJ-PRO-WSJ.com, wsjhealth
